Literature DB >> 34167467

Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke.

Tangqin Zhang1, Chu Chen1, Xiangjun Xu1, Junfeng Xu1, Ke Yang1, Youqing Xu1, Lili Yuan1, Qian Yang1, Xianjun Huang2, Zhiming Zhou3.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of our study was to analyse endovascular treatment (EVT) in patients presenting acute anterior circulation ischemic stroke with large-vessel occlusion (AIS-LVO) during the pandemic and post-epidemic periods.
METHODS: Patients with AIS-LVO of the anterior circulation who underwent EVT were enrolled. According to the times of Wuhan closure and reopening, patients were divided into a pre-pandemic group (from November 8, 2019, to January 22, 2020), pandemic group (from January 23, 2020, to April 8, 2020) and post-epidemic group (from April 9, 2020, to June 24, 2020). The primary endpoints were the time delay among symptom onset to arriving hospital door, to groining puncture and to vascular reperfusion. Secondary endpoints were the functional outcomes evaluated by 90-day modified Rankin scale (mRS) score.
RESULTS: In total, the times from onset to reperfusion (OTR, median 356 min vs. 310 min, p = 0.041) and onset to door (OTD, median 238 min vs. 167 min, p = 0.017) were prolonged in the pandemic group compared to the pre-pandemic group, and the delay continue in the post-epidemic period. In the subgroup analysis, the time from door to imaging (DTI) was significantly prolonged during the pandemic period. Interestingly, the prolonged DTI was corrected in the directly admitted subgroup during post-epidemic period. In addition, the functional outcomes showed no significant differences across the three periods.
CONCLUSIONS: Total time and prehospital time were prolonged during the pandemic and post-epidemic periods. Urgent public education and improved in-hospital screening processes are necessary to decrease time delays.

Entities:  

Keywords:  Acute ischaemic stroke; COVID-19; Endovascular treatment; Pandemic; Post-epidemic

Year:  2021        PMID: 34167467     DOI: 10.1186/s12883-021-02262-0

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  18 in total

1.  Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy?

Authors:  Steven D Hajdu; Valerie Pittet; Francesco Puccinelli; Wagih Ben Hassen; Malek Ben Maacha; Raphaël Blanc; Sandra Bracco; Gabriel Broocks; Bruno Bartolini; Tommaso Casseri; Frederic Clarençon; Olivier Naggara; François Eugène; Jean-Christophe Ferré; Alexis Guédon; Emmanuel Houdart; Timo Krings; Pierre Lehmann; Nicola Limbucci; Paolo Machi; Juan Macho; Nicolo Mandruzzato; Sergio Nappini; Marie Teresa Nawka; Patrick Nicholson; João Pedro Marto; Vitor Pereira; Manuel A Correia; Teresa Pinho-E-Melo; João Nuno Ramos; Eytan Raz; Patrícia Ferreira; João Reis; Maksim Shapiro; Eimad Shotar; Noel van Horn; Michel Piotin; Guillaume Saliou
Journal:  Stroke       Date:  2020-07-01       Impact factor: 7.914

2.  Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona.

Authors:  Salvatore Rudilosso; Carlos Laredo; Víctor Vera; Martha Vargas; Arturo Renú; Laura Llull; Víctor Obach; Sergio Amaro; Xabier Urra; Ferrán Torres; Francesc Xavier Jiménez-Fàbrega; Ángel Chamorro
Journal:  Stroke       Date:  2020-05-22       Impact factor: 7.914

3.  Impact of the COVID-19 pandemic on the process and outcome of thrombectomy for acute ischemic stroke.

Authors:  Bin Yang; Tao Wang; Jian Chen; Yanfei Chen; Yabing Wang; Peng Gao; Guilin Li; Fei Chen; Long Li; Zheng Wang; Hongqi Zhang; Haiqing Song; Qingfeng Ma; Liqun Jiao
Journal:  J Neurointerv Surg       Date:  2020-05-25       Impact factor: 5.836

4.  COVID-19 control in China during mass population movements at New Year.

Authors:  Simiao Chen; Juntao Yang; Weizhong Yang; Chen Wang; Till Bärnighausen
Journal:  Lancet       Date:  2020-02-24       Impact factor: 79.321

5.  Covid-19 - Navigating the Uncharted.

Authors:  Anthony S Fauci; H Clifford Lane; Robert R Redfield
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  Break in the Stroke Chain of Survival due to COVID-19.

Authors:  Joan Montaner; Ana Barragán-Prieto; Soledad Pérez-Sánchez; Irene Escudero-Martínez; Francisco Moniche; José Antonio Sánchez-Miura; Lidia Ruiz-Bayo; Alejandro González
Journal:  Stroke       Date:  2020-05-29       Impact factor: 7.914

7.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak.

Authors:  Matteo Chinazzi; Jessica T Davis; Marco Ajelli; Corrado Gioannini; Maria Litvinova; Stefano Merler; Ana Pastore Y Piontti; Kunpeng Mu; Luca Rossi; Kaiyuan Sun; Cécile Viboud; Xinyue Xiong; Hongjie Yu; M Elizabeth Halloran; Ira M Longini; Alessandro Vespignani
Journal:  Science       Date:  2020-03-06       Impact factor: 47.728

8.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19

9.  Ischaemic stroke in the time of coronavirus disease 2019.

Authors:  H Tejada Meza; Á Lambea Gil; A Sancho Saldaña; C Villar Yus; B Pardiñas Barón; D Sagarra Mur; J Marta Moreno
Journal:  Eur J Neurol       Date:  2020-06-18       Impact factor: 6.288

10.  Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain.

Authors:  H Tejada Meza; Á Lambea Gil; A Sancho Saldaña; M Martínez-Zabaleta; E Garmendia Lopetegui; E López-Cancio Martínez; M Castañón Apilánez; M Herrera Isasi; J Marta Enguita; B Gómez-Vicente; J F Arenillas; N Arenaza Basterrechea; J J Timiraos Fernández; J Sánchez Herrero; J L Maciñeiras Montero; M Castellanos Rodrigo; D Fernández-Coud; I Casado Menéndez; M T Temprano Fernández; M Freijo; A Luna; E J Palacio Portilla; Y Jiménez López; E Rodríguez-Castro; M Rodríguez-Yáñez; J Tejada García; I Beltrán Rodríguez; F Julián-Villaverde; M P Moreno García; J M Trejo Gabriel-Galán; A Echavarría Iñiguez; C Pérez Lázaro; M P Navarro Pérez; J Marta Moreno
Journal:  Eur J Neurol       Date:  2020-09-04       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.